Daehan New Pharm Co. Ltd (054670.KQ) stock: key figures, P/E, revenue and dividend

Energy · Coal & Consumable Fuels · South Korea · ISIN KR7054670005

Price
5,080.00 KRW
Market cap
71.30 bn KRW
P/E (2025)
4.67
P/S (2025)
0.35
Dividend yield
1.97 %
Net margin
7.54 %
Return on equity (ROE)
10.90 %
Return on assets (ROA)
5.63 %

Daehan New Pharm Co. Ltd financials

Fiscal year20242025
Revenue202.19 bn KRW202.40 bn KRW
Gross profit96.88 bn KRW92.26 bn KRW
Operating income18.67 bn KRW11.72 bn KRW
EBIT20.14 bn KRW16.65 bn KRW
Net income15.47 bn KRW15.26 bn KRW
Diluted EPS – continuing operations1,102.08 KRW1,087.09 KRW

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Daehan New Pharm Co. Ltd

Daehan Nupharm Co.,Ltd. manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally. It offers pharmaceuticals drugs for cardiovascular, endocrine system, neuropsychiatric, gastrointestinal, respiratory system, antipyretic, analgesic, anti-inflammatory, anti-infective, musculoskeletal, osteoporosis, anti-cancer, urogenital system, antifungal, antiviral, hormones, dermatologic, central nervous system, anticonvulsive, amino acid, anesthetic, antiobesity, and others; vitamins; and inorganic products. The company also provides animal health and nutrition products; health supplements; and aesthetic/medical devices. The company was formerly known as Daehan New Pharm Co., Ltd and changed its name to Daehan Nupharm Co.,Ltd. in March 2025. Daehan Nupharm Co.,Ltd. was founded in 1984 and is headquartered in Hwaseong-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.